Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | NRBO | APRE | ||
| Company | Kala Bio Inc | Neurobo Pharmaceuticals Inc | Aprea Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.98 | 3.57 | 2.95 | ||
| High | 6.05 | 3.57 | 2.95 | ||
| Low | 5.80 | 3.26 | 2.92 | ||
| Last | 5.80 | 3.26 | 2.92 | ||
| Change | unch | -0.14 | +0.06 | ||
| % Change | unch | -4.12% | +2.10% | ||
| Volume | 12,500 | 61,700 | 6,100 | ||
| 20-Day Average Volume | 8,470 | 39,830 | 7,040 | ||
| Previous Close | 5.80 | 3.40 | 2.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.92 | 3.54 | 3.32 | ||
| 20-Day Raw Stochastic | 14.89% | 3.63% | 6.00% | ||
| 20-Day Relative Strength | 43.70% | 40.41% | 36.62% | ||
| Weighted Alpha | -46.74 | -45.31 | -45.03 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 96% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.52% since 09/12/24 | -10.68% since 09/12/24 | -14.62% since 09/12/24 | ||
| Low | 5.73 on 09/17/24 | 3.26 on 09/19/24 | 2.86 on 09/18/24 | ||
| High | 6.20 on 09/13/24 | 3.82 on 09/13/24 | 3.32 on 09/13/24 | ||
| 1-Month | |||||
| %Chg | -7.64% since 08/19/24 | -13.30% since 08/19/24 | -22.85% since 08/19/24 | ||
| Low | 5.73 on 09/17/24 | 3.22 on 09/04/24 | 2.86 on 09/18/24 | ||
| High | 6.42 on 08/21/24 | 4.32 on 09/09/24 | 3.86 on 08/22/24 | ||
| 3-Month | |||||
| %Chg | +11.54% since 06/18/24 | -15.10% since 06/18/24 | -28.26% since 06/18/24 | ||
| Low | 4.21 on 06/26/24 | 3.22 on 09/04/24 | 2.86 on 09/18/24 | ||
| High | 7.88 on 07/15/24 | 5.30 on 06/27/24 | 4.34 on 06/25/24 | ||
| 6-Month | |||||
| %Chg | -24.87% since 03/19/24 | -20.68% since 03/19/24 | -56.68% since 03/19/24 | ||
| Low | 4.21 on 06/26/24 | 2.99 on 04/24/24 | 2.86 on 09/18/24 | ||
| High | 8.12 on 04/02/24 | 5.30 on 06/27/24 | 6.80 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,336 | 16,680 | 15,530 | ||
| Shares Outstanding, K | 2,816 | 4,906 | 5,430 | ||
| Annual Sales | 0 | 0 | 580,000 | ||
| Annual Net Income | -42,200,000 | -12,470,000 | -14,290,000 | ||
| Last Quarter Sales | 0 | 0 | 560,000 | ||
| Last Quarter Net Income | -9,580,000 | -10,050,000 | -3,470,000 | ||
| 60-Month Beta | -2.12 | -0.28 | 1.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.16 on 08/06/24 | -1.85 on 08/14/24 | -0.58 on 08/12/24 | ||
| Latest Earnings Date | 11/11/24 | 11/11/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||